gefitinib has been researched along with cytochalasin b in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (cytochalasin b) | Trials (cytochalasin b) | Recent Studies (post-2010) (cytochalasin b) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 5,088 | 4 | 234 |
| Protein | Taxonomy | gefitinib (IC50) | cytochalasin b (IC50) |
|---|---|---|---|
| Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (human) | 4.1 | |
| Solute carrier family 2, facilitated glucose transporter member 3 | Homo sapiens (human) | 3.9 | |
| Solute carrier family 2, facilitated glucose transporter member 4 | Homo sapiens (human) | 3.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kunieda, Y; Tominaga, M; Uto, Y; Yamada, H; Yamahana, H | 1 |
1 other study(ies) available for gefitinib and cytochalasin b
| Article | Year |
|---|---|
Development of a novel acetyl glucose-modified gefitinib derivative to enhance the radiosensitizing effect.
Topics: Antineoplastic Agents; Biomedical Enhancement; Cell Line, Tumor; Cell Membrane Permeability; ErbB Receptors; Gefitinib; Glucose; Glucose Transport Proteins, Facilitative; Glycolysis; Humans; Monosaccharide Transport Proteins; Nitroimidazoles; Phosphorylation; Radiation-Sensitizing Agents | 2021 |